LWAC
FOLD

Laurel Wealth Advisors (California)’s Amicus Therapeutics FOLD Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$265K Buy
+21,702
New +$244K 0.03% 542
2022
Q2 		– Sell
-25,656
Closed -$243K – 690
2022
Q1 		$243K Sell
25,656
-184
-0.7% -$1.73K 0.02% 652
2021
Q4 		$298K Buy
+25,840
New +$288K 0.02% 625

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Laurel Wealth Advisors (California)'s FOLD Position: Q4 2022 in Review

Laurel Wealth Advisors (California) opened a new position in Amicus Therapeutics (FOLD) in Q4 2022: 21,702 shares worth $265K. The stake represents 0.03% of the portfolio and ranks #542 among its holdings. This is a return to the name: Laurel Wealth Advisors (California) previously reported a position in FOLD as recently as Q1 2022.

Laurel Wealth Advisors (California) first reported a position in FOLD in Q4 2021 and has held it in 3 quarters since. The position peaked at $298K in Q4 2021. 230 funds tracked by Wall St. Rank hold FOLD as of Q4 2022.

  • Laurel Wealth Advisors (California) held 21,702 shares of Amicus Therapeutics worth $265K as of Q4 2022.
  • Amicus Therapeutics was a new Laurel Wealth Advisors (California) position in Q4 2022.
  • Amicus Therapeutics made up 0.03% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #542 holding.
  • Laurel Wealth Advisors (California) first reported a position in Amicus Therapeutics in Q4 2021 and has held it in 3 quarters since.
  • Laurel Wealth Advisors (California)'s Amicus Therapeutics position peaked at $298K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.